Alzheimer’s disease: clinical trials and drug development.
Lancet Neurol. 2010; 9: 702-716
Neurotoxicity of amyloid beta-protein: synaptic and network dysfunction.
Cold Spring Harb Perspect Med. 2012; 2a006338
The case for rejecting the amyloid cascade hypothesis.
Nat. Neurosci. 2015; 18: 794-799
Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases.
Nature. 2006; 443: 787-795
Oxidative stress, synaptic dysfunction, and Alzheimer’s disease.
J. Alzheimers Dis. 2017; 57: 1105-1121
Biological activities of curcuminoids, other biomolecules from turmeric and their derivatives – a review.
J. Tradit. Complement. Med. 2017; 7: 205-233
Curcumin: biological, pharmaceutical, nutraceutical, and analytical aspects.
Molecules. 2019; 24
Curcumin has potent anti-amyloidogenic effects for Alzheimer’s beta-amyloid fibrils in vitro.
J. Neurosci. Res. 2004; 75: 742-750
The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse.
J. Neurosci. 2001; 21: 8370-8377
Curcumin alters the salt bridge-containing turn region in amyloid beta(1-42) aggregates.
J. Biol. Chem. 2014; 289: 11122-11131
Inhibition of lipid peroxidation and protein oxidation in rat liver mitochondria by curcumin and its analogues.
Biochim. Biophys. Acta. 2006; 1760: 70-77
Scavenging mechanism of curcumin toward the hydroxyl radical: a theoretical study of reactions producing ferulic acid and vanillin.
J. Phys. Chem. A. 2011; 115: 14221-14232
Design, structure activity relationship, cytotoxicity and evaluation of antioxidant activity of curcumin derivatives/analogues.
Eur. J. Med. Chem. 2016; 121: 510-516
Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer’s disease animal models.
J. Alzheimers Dis. 2004; 6 : 367-377
Curcumin activates human glutathione S-transferase P1 expression through antioxidant response element.
Toxicol. Lett. 2007; 170: 238-247
Effect of curcumin on the metal ion induced fibrillization of amyloid-beta peptide.
Spectrochim. Acta A Mol. Biomol. Spectrosc. 2014; 117: 798-800
Resveratrol as a therapeutic agent for Alzheimer’s disease.
Biomed. Res. Int. 2014; 2014350516
Resveratrol promotes clearance of Alzheimer’s disease amyloid-beta peptides.
J. Biol. Chem. 2005; 280: 37377-37382
Neuroprotective action of resveratrol.
Biochim. Biophys. Acta. 2015; 1852: 1195-1201
Protective effect of epsilon-viniferin on beta-amyloid peptide aggregation investigated by electrospray ionization mass spectrometry.
Bioorg. Med. Chem. 2011; 19: 3152-3155
Potential mechanism by which resveratrol, a red wine constituent, protects neurons.
Ann. N Y Acad. Sci. 993. 2003; (): 276-286
Resveratrol potently reduces prostaglandin E2 production and free radical formation in lipopolysaccharide-activated primary rat microglia.
J. Neuroinflammation. 2007; 4: 25
Protective effect of resveratrol on beta-amyloid-induced oxidative PC12 cell death.
Free Radic. Biol. Med. 2003; 34: 1100-1110
Biological and computational evaluation of resveratrol inhibitors against Alzheimer’s disease.
J. Enzyme Inhib. Med. Chem. 2016; 31: 67-77
Potent induction of cellular antioxidants and phase 2 enzymes by resveratrol in cardiomyocytes: protection against oxidative and electrophilic injury.
Eur. J. Pharmacol. 2004; 489: 39-48
Pre and post treatment with curcumin and resveratrol protects astrocytes after oxidative stress.
Brain Res. 2018; 1692: 45-55
Naturally occurring phytochemicals for the prevention of Alzheimer’s disease.
J. Neurochem. 2010; 112: 1415-1430
Edaravone: a new drug approved for ALS.
Cell. 2017; 171: 725
Edaravone reduces Abeta-induced oxidative damage in SH-SY5Y cells by activating the Nrf2/ARE signaling pathway.
Life Sci. 2019; 221: 259-266
The efficacy of edaravone (radicut), a free radical scavenger, for cardiovascular disease.
Int. J. Mol. Sci. 2013; 14: 13909-13930
Edaravone alleviates Alzheimer’s disease-type pathologies and cognitive deficits.
Proc. Natl. Acad. Sci. U. S. A. 2015; 112: 5225-5230
Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins.
Proc. Natl. Acad. Sci. U. S. A. 1998; 95: 6448-6453
Wei, A11-positive beta-amyloid oligomer preparation and assessment using dot blotting analysis.
J. Vis. Exp. 2018; 135
Considerations for the use of SH-SY5Y neuroblastoma cells in neurobiology.
Methods Mol. Biol. 2013; 1078: 9-21
Use of human neuroblastoma SH-SY5Y cells to evaluate glyphosate-induced effects on oxidative stress, neuronal development and cell death signaling pathways.
Environ. Int. 2020; 135105414
A synthetic cell permeable antioxidant protects neurons against acute oxidative stress.
Sci. Rep. 2017; 7: 11857
Different conformations of amyloid beta induce neurotoxicity by distinct mechanisms in human cortical neurons.
J. Neurosci. 2006; 26: 6011-6018
Abeta toxicity in Alzheimer’s disease: globular oligomers (ADDLs) as new vaccine and drug targets.
Neurochem. Int. 2002; 41: 345-352
Abeta oligomers trigger and accelerate Abeta seeding.
Brain Pathol. 2020; 30: 36-45
The Alzheimer’s disease mitochondrial cascade hypothesis.
J. Alzheimers Dis. 2010; 20: S265-S279
Estrogen amelioration of Abeta-induced defects in mitochondria is mediated by mitochondrial signaling pathway involving ERbeta, AKAP and Drp1.
Brain Res. 2015; 1616: 101-111